API
Trimebutine Maleate
KDMF APIs
Trimebutine Maleate
Korean name | 트리메부틴말레산염 |
|---|---|
Category | Digestive organs |
CAS No. | 34140-59-5 |
KDMF registration No. | 20060302-13-B-231-05(1) |
Manufacturer | Zhejiang East-Asia Pharmaceutical Co.,Ltd |
Specification | KP |
Product information
IUPAC Name | (2Z)-but-2-enedioic acid; 2-(dimethylamino)-2-phenylbutyl 3,4,5-trimethoxybenzoate |
|---|---|
Synonyms | 2-Dimethylamino-2-phenylbutyl 3,4,5-trimethoxybenzoat |
Description | Trimebutine is a spasmolytic agent that regulates intestinal and colonic motility and relieves abdominal pain with antimuscarinic and weak mu opioid agonist effects. It is marketed for the treatment of irritable bowel syndrome (IBS) and lower gastrointestinal tract motility disorders, with IBS being one of the most common multifactorial GI disorders. It is used to restore normal bowel function and is commonly present in pharmaceutical mixtures as trimebutine maleate salt form. Trimebutine is not a FDA-approved drug, but it is available in Canada and several other international countries. |
Certificate of Analysis | If you need more information, please contact us. |
If you need additional documents such as specifications or certificates of analysis, please request them together with your inquiry. Our team will review and reply. (02-579-1056 · ace@acebiopharm.com)